Home Ligand Pharmaceuticals Lowered to Hold at Zacks
 

Keywords :   


Ligand Pharmaceuticals Lowered to Hold at Zacks

2015-08-23 17:16:33| Biotech - Topix.net

According to Zacks, "Ligand delivered better-than-expected second-quarter results with the company beating both top- and bottom-line estimates. Ligand's Captisol formulation technology has resulted in partnerships with several leading health care companies like Novartis, Amgen and Pfizer among others that provide the company with funds in the form of milestone and royalty payments.

Tags: hold lowered pharmaceuticals ligand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
31.10Essity Named Diversity Leader by Financial Times
31.10Maxcess to Make FIFE Guiding Products in Mumbai
More »